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Editorial 
Obstructive symptoms in athletes: is it asthma and 
what to do about it? 
Asthma symptoms recorded as wheezing, abnor- 
mal breathlessness or cough induced by exercise are 
commonly reported among top athletes. In recent 
years, asthma has been defined by a combination of 
clinical and pathological criteria, with the latter being 
characterized by a chronic inflammation in the bron- 
chial mucosa, including the activation of eosinophils, 
lymphocytes and endothelial cells. In the clinical 
setting, asthma is characterized by increased bron- 
chial responsiveness to various stimuli, resulting in 
variable bronchial obstruction. Whether the obstruc- 
tive symptoms reported by top performing athletes 
are due to the presence of airway inflammation, or 
should be considered as a normal physiological 
response to an extreme exposure is under debate. 
The prevalence of asthma in athletes has been 
reported in a number of papers. These figures 
vary considerably. About 9% of Australian Olympic 
athletes in 1976 and 1980, with a predominance of 
swimmers, reported asthma (1). In the U.S. Olympic 
team in Los Angeles 1984, 4.4% had self-reported 
disease (2) while 3.7% of 2060 Swiss athletes 
reported the disease in a questionnaire study (3). A 
higher prevalence of exercise-induced asthma (EIA) 
was reported in both populations: 11.2% in the U.S. 
team and 7.1% in the Swiss athletes. Neither of these 
reports included a control population. The highest 
prevalence of questionnaire-reported asthma has 
been found in cross-country skiers. A past or present 
history of asthma was reported by 14% of skiers and 
5% of controls in Norway (4), while the correspond- 
ing figures in a Swedish study were 15 and 6% 
respectively (5). 
There are few reports on provocation tests 
in athletes. New athletes at the University of 
Washington 1979-1981 were screened for EIA using 
a structured interview. Symptomatic individuals were 
subjected to an exercise test and 2.8% were found to 
have EIA (6). Methacholine provocation was per- 
formed in 151 American football players. A high 
proportion (50%) were found to have bronchial 
hyper-responsiveness but this also was the case in 
41% of the students used as controls and 25% of 
basketball players (7). In a study of 42 Swedish elite 
0954-6111/96/010001+03 $12.0010 
cross-country skiers, 38% were hyper-reactive to 
methacholine compared to 7% of the 29 controls; an 
additional 2 1% (n = 9) had been previously diagnosed 
with asthma and used inhaled steroids but were not 
hyper-reactive at the time of the survey (8). 
It can be concluded that presently there are not, to 
our knowledge, any convincing data supporting the 
assumption that asthma is more common in athletes 
other than cross-country skiers. Even though bron- 
chial hyper-responsiveness and asthma symptoms 
seem to be more common in cross-country skiers, it 
has still to be established whether ‘skiers’ asthma’ 
represents a separate entity, or can be synonymous 
with the morphologically-defined asthma in a 
broader sense. Exercise and cold air exposure are well 
known trigger factors in susceptible individuals, and 
most asthmatics report symptoms from physical exer- 
cise (9,lO). Whether cold air exposure may itself 
induce an inflammatory response or only act as a 
trigger factor on susceptible individuals is still an 
open question. A transient increase in bronchial 
responsiveness by inhalation of cold and dry air has 
been reported in asthmatic (11) as well as in healthy 
(12) individuals. A late obstructive response after 
exercise test is occasionally seen in individuals with 
asthma, indicating that inflammation may be induced 
by exercise - at least in some individuals (13). A 
transient increase in the number of eosinophils and 
eosinophilic cationic protein (ECP) (14), as well as 
a raised serum level of histamine (15), has been 
reported after exercise in asthmatics. Moreover the 
antihistamine, terfenadine, has been shown to partly 
inhibit the obstructive response induced by hyper- 
ventilation with cold air, indicating that mast cells 
may be pathophysiologically involved (16). Thus, it 
seems reasonable to assume that inflammation is a 
substantial part of EIA. The findings of an increased 
rate of bronchial hyper-reactivity among cross- 
country skiers suggests that the high prevalence of 
airway symptoms is due to airway inflammation in 
this group. As these findings indicate that persistent 
intlammation may be induced by cold and dry air (8), 
the nature of the changes in skiers needs to be studied 
more carefully, preferably with invasive techniques, 
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i.e. bronchoscopy. If the changes in ‘skiers’ asthma’ 
correspond to those in asthma in other individuals, it 
seems probable that cold and dry air are not only 
asthma triggers, but also possible asthma inducers. 
The results presented by Sue-Chu et al. support the 
assumption that the climate influences the symptoms 
in skiers (17). 
A dry inland climate has, in population studies, 
been shown to be associated with more asthma 
symptoms compared to humid coastal climates in 
Sweden (18), and warmer climates in Saudi Arabia 
(19). This indicates that airway drying may be as 
important as airway cooling per se. This is in accord- 
ance with results reported by Bar-Or et al. (20) and 
by Anderson et al. (21), while others advocate cold as 
the principle hazard factor (22). 
It seems reasonable to believe that the small differ- 
ences observed in the general population, possibly 
due to climate factors, may be considerably larger in 
a population that expose themselves to the climate 
in an extreme way during cross-country skiing. 
This underlines the importance of a multifactorial 
approach to asthma when considering why asthma 
seems to be an increasing problem in the industrial- 
ized world. 
As the causes of asthma in athletes seems to be 
multifactorial, the treatment and especially preven- 
tive measurements, should be multifactorial. We 
suggest that the presence of asthma symptoms in 
combination with bronchial hyper-responsiveness or 
the presence of exercise-induced obstructive response 
should, until we know more, be handled and treated 
in line with general asthma management, as we know 
it today. This means a combined use of anti- 
inflammatory drugs, preferably inhaled steroids, and 
bronchodilators taken as rescue medication and 
before exercise. It should be noted that the use of 
long acting &agonists is banned as doping by the 
IOC (International Olympic Committee) and should 
therefore not be used by competitive athletes. 
&agonist treatment may enhance muscle strength in 
experimental settings (23). In practice, however, it 
has been impossible to show any effects of &agonist 
treatment which support the theory of &agonist as a 
doping agent. On the contrary, &agonist treatment 
has been shown to increase ventilation-perfusion 
mismatching in asthmatics (24). This negative effect 
of &agonist treatment seems to be balanced by the 
increased ventilatory capacity caused by broncho- 
dilatation. In healthy individuals, neither of these 
responses occurred, and no positive net effect on 
performance was seen in healthy endurance athletes 
by salbutamol (25, 26) nor by 3 mg of inhaled 
terbutaline when tested in cold chamber (unpubl. 
data). The use of disodium chromoglycate (DSCG) 
or nedocromile before exercise is an alternative 
preventive measure which is usually somewhat less 
effective, but the combination of DSCG with 
&agonist treatment can act synergistically (27-29). 
However, it needs to be stressed that medication 
alone should not be regarded as the solution for 
asthma problems in athletes. It is essential to mini- 
mize the exposure to other risk factors, for example 
training/competition close to a respiratory tract infec- 
tion. Some viral infections (e.g. RSV, adenovirus, 
para-influenza etc.) have been shown to cause a 
prolonged bronchial hyper-responsiveness in suscep- 
tible individuals. It is not known how long athletes 
should refrain from training after recovering from an 
infection, but the ‘safe’ time is probably more than 
1 week. It is also probable that the present tempera- 
ture limit in cross-country skiing ( - 20°C in inter- 
national competitions) is far too low. We suggest that 
the temperature limit should not decrease below 
- 1X, and for young individuals, this limit should 
be even higher. It is also important to stress the use of 
heat exchangers in training and warming-up. This 
equipment not only raises temperature, but also 
humidifies inspired air. 
A careful warm-up is also mandatory for reducing 
the problems with exercise-induced obstruction. The 
individuals should be instructed to start warm-up not 
less than 45 rein before competition. The warm-up 
sequence should be individualized, but include events 
of sub-maximal or close to maximal periods, with the 
purpose of inducing refractoriness against later 
obstructive responses (30). 
In summary, it can be concluded that asthma is 
seen more frequently in cross-country skiing athletes 
than control subjects, while the pattern in other 
sports is unclear. The exposure to cold and dry air 
is probably the main cause of this increased risk. It 
is still unclear whether the asthma seen in these 
individuals has the same morphological pattern as 
the asthma seen in non-athletes. However, the fmd- 
ings of increased bronchial hyper-responsiveness 
parallel with asthma symptoms, advocates the 
assumption of airway inflammation in both sets of 
individuals. Treatment should be directed toward 
the decrease of known trigger or risk factors with 
training restrictions in low temperatures. Further- 
more, athletes should avoid training in connection 
with recent respiratory tract infections. A careful 
warm-up of sullicient duration, preferably combined 
with heat exchange equipment, helps reduce the 
symptoms. 
Until we acquire more information on the patho- 
physiological mechanisms involved in these defined 
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settings, the athletes with asthma problems should be 
medically treated in accordance with the tradition 
established for all asthmatics. To date, there is no 
evidence that asthma medication, including long- 
acting &agonist treatment, could enhance perform- 
ance in healthy non-asthmatic athletes, in spite of the 
IOC doping rules. 
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